ac21 - richard kim: which cholangiocarcinoma patients benefit from immunotherapy?
Published 3 years ago • 375 plays • Length 19:03Download video MP4
Download video MP3
Similar videos
-
20:12
ac21 - oliver klein: immunotherapy combinations
-
19:13
ac21 - tim pawlik: surgical management of intrahepatic cholangiocarcinoma
-
16:09
ac21 - panel discussion: locoregional management of cholangiocarcinoma
-
18:15
ac21 - nilo azad: the future of personalized vaccines in cholangiocarcinoma
-
7:22
ac21 - gonzalo sapisochin: management of perihilar cholangiocarcinoma - surgical transplant
-
12:37
ac21 - ardaman shergill: mapk pathway targeting in cholangiocarcinoma
-
23:14
ac21 - panel discussion: updates on genomically informed therapy in cca
-
56:28
webinar: “the perio-02 trial – enabling immunotherapy for intrahepatic cholangiocarcinoma”
-
35:30
ac22 - cholangiocarcinoma updates panel discussion
-
11:51
ac21 - ryan fields: cca participant engagement & cancer genome sequencing u2c cancer moonshot prog.
-
12:45
ac21 - discussion panel: advances in immuno-oncology
-
10:59
ac21 - ryan fields: definition of perihilar cholangiocarcinoma
-
1:16
richard kim, md, regarding targeted therapies in treatment of cholangiocarcinoma
-
8:44
ac21 - sophia cornew: ciitizen's clinical trial finder
-
11:56
ac21 - ghassan abou-alfa: fgfr
-
13:22
ac21 - r. mark ghobrial: liver transplantation for intrahepatic cholangiocarcinoma
-
1:53:47
ac23 - session iii: immunotherapy: where we are and where we're going?
-
10:56
ac21 - christine kang: imaging of perihilar cholangiocarcinoma
-
1:03:30
webinar: can local therapies help patients with intrahepatic cholangiocarcinoma?